KOSDAQ - Delayed Quote KRW

Seegene, Inc. (096530.KQ)

33,250.00 -350.00 (-1.04%)

At close: 3:30:08 PM GMT+9

Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

PR Newswire 3mo ago

096530.KQ
-1.04%
Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows

CNW Group 6mo ago

096530.KQ
-1.04%
Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows

PR Newswire 6mo ago

096530.KQ
-1.04%
Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

CNW Group 3mo ago

096530.KQ
-1.04%
Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

PR Newswire 3mo ago

096530.KQ
-1.04%
Seegene USA Receives FDA Emergency Use Authorization for Multiplex PCR Assay, Advancing Differential Diagnosis of HSV-1&2, VZV, and Monkeypox Virus for Ulcerative Skin Lesions

PR Newswire 3mo ago

096530.KQ
-1.04%
Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing

CNW Group 3mo ago

096530.KQ
-1.04%
Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing

PR Newswire 3mo ago

096530.KQ
-1.04%
Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards

PR Newswire 3mo ago

096530.KQ
-1.04%
Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards

CNW Group 3mo ago

096530.KQ
-1.04%
ADLM announces 2026 Top Corporate Supporter Award recipients and thanks them for their essential backing

PR Newswire 3mo ago

QDEL

TMO

BIO
Asian Market Highlights 3 Stocks Possibly Trading Below Intrinsic Value Estimates

Simply Wall St. 11mo ago

600326.SS

096530.KQ
-1.04%
6480.T

U.S. markets closed

Seegene, Inc. (096530.KQ)

Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows

Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows

Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

Seegene USA Receives FDA Emergency Use Authorization for Multiplex PCR Assay, Advancing Differential Diagnosis of HSV-1&2, VZV, and Monkeypox Virus for Ulcerative Skin Lesions

Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing

Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing

Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards

Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards

ADLM announces 2026 Top Corporate Supporter Award recipients and thanks them for their essential backing

Asian Market Highlights 3 Stocks Possibly Trading Below Intrinsic Value Estimates